A phase I/II multiple ascending dose study of BMS-777607 in subjects with advanced or metastatic solid tumors.
Phase of Trial: Phase I/II
Latest Information Update: 08 Mar 2017
At a glance
- Drugs BMS 777607 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Mar 2008 New trial record.